ABCG2 and leukemia: Xu et al. observed a positive correlation between HIF1α and ABCG2 expression [127], suggesting that HIF1α could be considered a prognostic indicator in AMLs and making HIF1α a potential therapeutic target to down-modulate ABCG2 expression and eliminate leukemia stem cells [128].